Catheters News and Research

RSS

WHO releases new report on spinal cord injury

As many as 500 000 people suffer a spinal cord injury each year. People with spinal cord injuries are 2 to 5 times more likely to die prematurely, with worse survival rates in low- and middle-income countries. The new WHO report, "International perspectives on spinal cord injuries", summarizes the best available evidence on the causes, prevention, care and lived experience of people with spinal cord injury.

2 Dec 2013

University of Wisconsin Hospital and Clinics recognized with 2013 Partnership in Prevention Award

The U.S. Department of Health and Human Services (HHS), the Association for Professionals in Infection Control and Epidemiology (APIC), and the Society for Healthcare Epidemiology of America (SHEA) today recognized the University of Wisconsin Hospital and Clinics (UWHC) with the 2013 Partnership in Prevention Award for achieving sustainable improvements towards eliminating healthcare-associated infections (HAIs).

27 Nov 2013

Researchers report long-term benefits of gene therapy in advanced heart failure patients

Researchers from the Cardiovascular Research Center at Icahn School of Medicine at Mount Sinai reported the long-term benefits of a single dose of their gene therapy AAV1/SERCA2a in advanced heart failure patients on Nov. 19 at the American Heart Association Scientific Sessions 2013.

20 Nov 2013

Risk of dangerous bloodstream infections can be reduced in newborns with central venous catheters

A new study led by Johns Hopkins Children's Center investigators shows that clinicians can reduce the risk of dangerous bloodstream infections in newborns with central venous catheters by ending use of the device as soon as possible, rather than waiting for signs of infection.

11 Nov 2013

Topera receives FDA clearance for FIRMap Catheter

Topera, Inc., a medical device company that has developed a novel mapping and targeting system for the identification of the sources that sustain complex cardiac arrhythmias, today announced that it has received 510(k) clearance by the U.S. Food and Drug Administration for the FIRMap Catheter.

7 Nov 2013

Healthcare-associated infections are less likely to occur in favorable critical care work environments

Healthcare-associated infections (HAIs) are less likely to occur in favorable critical care work environments, according to a study of more than 3,200 nurses in the November issue of American Journal of Critical Care (AJCC).

4 Nov 2013

Identifying gaps in infection prevention practices may help improve patient safety, shows study

Identifying gaps in infection prevention practices may yield opportunities for improved patient safety, according to a survey published in the November issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

30 Oct 2013

Sanovas receives patent for Multi-Balloon Catheter for Extravasated Drug Delivery

Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.

29 Oct 2013

Residents of Orange County, California nursing homes carry community-associated MRSA

More than one quarter of residents of 26 nursing homes in Orange County, California carry community-associated methicillin-resistant Staphylococcus aureus, which spread more easily, and may cause more severe infection than MRSA traditionally associated with healthcare facilities, according to a paper published in the November 2013 issue of the Journal of Clinical Microbiology.

25 Oct 2013

Surefire Medical announces launch of new infusion system

Surefire Medical, Inc., today announced the launch of a new, enhanced infusion system – the Surefire Infusion System mT – designed to treat vessels as small as 2mm to 3.5mm in interventional direct-to-target embolization procedures.

18 Oct 2013

Use of antibiotics to treat catheter-associated bacteriuria infection show no change in mortality rates

With 30 million indwelling bladder catheters placed annually nationwide, patients face an increased risk of developing catheter-associated bacteriuria (bacteria in the urine). Many patients with indwelling urinary catheters acquire bacteria in the urinary tract while they are catheterized.

17 Oct 2013

New type of antibiotic kills multidrug-resistant germ common to health care settings

A new type of antibiotic called a PPMO, which works by blocking genes essential for bacterial reproduction, successfully killed a multidrug-resistant germ common to health care settings, UT Southwestern Medical Center researchers report.

16 Oct 2013

Bluhm Institute enrolls first patient in SALUS trial to evaluate movable, non-metallic heart valve

Northwestern's Bluhm Cardiovascular Institute has enrolled its first participant in SALUS, a clinical trial studying the effectiveness of a prosthetic aortic heart valve that can be placed without open-heart surgery.

10 Oct 2013

Recovery sleep over weekend may not reverse all effects of sleep lost during workweek

In many modern societies, adults often sacrifice sleep during the workweek to make time for other demands, then snooze longer on the weekends to recoup that lost sleep. Research has shown that even a few days of lost sleep can have adverse effects, including increased daytime sleepiness, worsened daytime performance, an increase in molecules that are a sign of inflammation in the body, and impaired blood sugar regulation.

10 Oct 2013

CARUNDA24: A non-invasive continuous blood pressure measurement system

Freienbach, Switzerland: About 1 in 4 people in Switzerland suffer from high blood pressure; worldwide more than 1 billion people are affected increasing the risk of heart attack, cerebral haemorrhage or a stroke. Unfortunately, most affected people don't measure their blood pressure regularly as the measurement method is too complicated and uncomfortable to be part of a daily routine.

8 Oct 2013

Winners of VCCircle Healthcare Awards announced

The event recognised medical professionals who have not only scaled in terms of clinical and financial performance but also played a role in making a difference in patients' lives.

7 Oct 2013

FDA expands Hizentra administration options for people with primary immunodeficiency

CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.

28 Sep 2013